Almost one billion people globally live in urban informal settlements. This burgeoning population is exposed to living conditions that may predispose them to differential disease burden.
We have field sites in Brazil, India and Bangladesh where we conduct studies to assess the burden of diseases in urban slum settlements. Products of our basic research (e.g., new diagnostic tests) are applied at our field sites to assess disease burden.
- Ebola in urban slums: the elephant in the room. The Lancet Global Health. 2014
- A comparison of social and spatial determinants of health between formal and informal settlements in a large metropolitan setting in Brazil. J Urban Health. 2014 Jun;91(3):432-45. PMID: 24297475
- Inverse association between Lancefield group G Streptococcus colonization and sore throat in slum and nonslum settings in Brazil. J Clin Microbiol. 2011
- Slum health: from understanding to action. PLoS Med. 2007
- Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet. 1999
The Riley Lab is committed to participatory research, engaging the community and making stakeholders out of those involved (local health professionals and research participants).
Check out the result of Robbie and Mariel's work in Niterói, Rio de Janeiro on youtube in which they designed and videotaped a diet-themed samba with residents of the Preventório community.